Press Release – Adipopharma

press releases

French biotech company AdipoPharma wins Series A funding for breakthrough diabetes drug

January 23, 2023

La société biotechnologique française AdipoPharma obtient un financement de série A pour un médicament révolutionnaire contre le diabète

January 23, 2023

New treatment set to benefit 1 in 20 Australians living with diabetes

September 2, 2022

DIABETES DRUG TO CORRECT METABOLIC ABNORMALITIES

September 2, 2022

First-in-Class Synthetic Peptide PATAS Promotes Insulin-Free Glucose Absorption

August 22, 2022

AdipoPharma Targets Root Cause Of Diabetes With First ‘Adipeutic’ Drug Candidate

August 5, 2022

New medicine class to treat type 2 diabetes

August 1, 2022

Towards a New Drug Class in the Treatment of Type 2 Diabetes

August 1, 2022

Monash University: Towards a New Drug Class in the Treatment of Type 2 Diabetes

July 22, 2022

AdipoPharma SAS – Headquarters
Nextmed, Bâtiment eXplora (Bureau A203)1907
2 rue Marie Hamm
67000 Strasbourg
France

AdipoPharma SRL
Biopark Gosselies
Belgique

AdipoPharma LLC
US Office Pittsburgh
Pennsylvania, USA

© 2025 AdipoPharma - Privacy Policy | Legal Notice | Management Of The Information Collected